Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease with a global prevalence of about 55% in people with type 2 diabetes mellitus (T2DM). T2DM, obesity and NAFLD are three closely inter-related pathological conditions. In addition, T2DM is one of the strongest...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Lei, Xu, Jing, Targher, Giovanni, Byrne, Christopher D, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597221/
https://www.ncbi.nlm.nih.gov/pubmed/35286799
http://dx.doi.org/10.3350/cmh.2022.0015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597221/
https://www.ncbi.nlm.nih.gov/pubmed/35286799
http://dx.doi.org/10.3350/cmh.2022.0015

Ejemplares similares